Infinity Pharmaceuticals reported $272K in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 571K 1.21M
Amgen AMGN:US $ 5084M 407M
AstraZeneca AZN:LN 728.3B 34.55B
Bristol Myers Squibb BMY:US $ 9210M 33M
Eisai 4523:JP Y 136858M 3305M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Gilead Sciences GILD:US $ 4818M 348M
GlaxoSmithKline GSK:LN 479.3B 29.3B
Infinity Pharmaceuticals INFI:US $ 0.27M 0.01M
Johnson & Johnson JNJ:US $ 16101M 273M
Novartis NOVN:VX 9.34B 277M
Pfizer PFE:US $ 19071M 3420M
Seattle Genetics SGEN:US $ 391.4M 52.57M
Vascular Biogenics VBLT:US 30K 28K
YTE INCY:US $ 866.16M 170.14M